SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing a surge in trading activity and market interest driven by reports of potential buyout discussions involving major tech players like Amazon, sparking speculation about a high-stakes bidding war. Investors are closely monitoring the strategic value of the company's satellite spectrum and its established partnerships, fueling ongoing debates about the potential acquisition price and its impact on the broader satellite communications sector.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is seeing significant price action following a strong earnings report that topped expectations, sparking a massive rally and a flurry of analyst price target upgrades. The community is sharply divided between bulls celebrating a long-awaited recovery and skeptics warning that the stock remains overextended and fundamentally vulnerable to sector-wide headwinds.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility and bullish momentum following a substantial new order from a hyperscale customer for its 800G data center transceivers. The community remains deeply divided, with some investors focusing on the company's growth within the AI infrastructure and photonics sector, while others argue the stock is overextended, heavily manipulated by hedge funds, and vulnerable to a sharp pullback.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

The community is intensely divided over XPL, with some traders highlighting the token's potential as a stablecoin infrastructure play while others express frustration over persistent price declines and concerns about tokenomics. Discussions are largely focused on identifying a potential bottom and speculating on whether recent volatility reflects genuine market movement or a prolonged exit for early holders.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors aggressively accumulate shares following a market-wide dip, driven by excitement over upcoming satellite launch catalysts and the broader space sector momentum surrounding a potential SpaceX IPO. Community members are actively debating the company's valuation relative to space industry peers and speculating on the strategic importance of its direct-to-device technology for major telecom partnerships.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as retail investors and institutions digest recent strategic partnerships, including AI infrastructure collaborations with Nvidia and major defense contracts like the SHIELD program. The community is actively discussing Nokia's evolution from a legacy handset maker to a high-tech AI networking powerhouse, with many traders leaning into long-term positions and LEAPs while debating the stock's consolidation patterns.

PolySwarm

PolySwarm is capturing significant community attention as traders highlight its role in cybersecurity and its position as a potential utility play within the growing AI-driven security sector. Investors are actively discussing the token's low circulating supply and its history of rapid, high-volume price swings, with many looking for a breakout as they monitor technical chart patterns and potential partnership developments.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is facing a pivotal turning point following a Complete Response Letter from the FDA, with investors closely watching the upcoming Type A meeting as a potential catalyst to clarify the regulatory path for its RP1 melanoma therapy. The community remains deeply divided, with some highlighting the strong clinical data and physician support as evidence of future approval, while others express concerns over cash runway, potential dilution, and the high hurdle of addressing FDA-requested clinical trial design changes.

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Relay Therapeutics Inc

Relay Therapeutics is trending as the community closely monitors updates on its pipeline and clinical programs, with investors weighing the potential for acquisition interest against broader sector volatility. Ongoing discussions emphasize the company's long-term promise in precision oncology, despite current market sentiment focusing on clinical milestones and trial outcomes.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

Kelly Services (KELYB) is currently the focus of intense speculation driven by its exceptionally low float and ongoing institutional and insider accumulation, leading many in the community to anticipate a short-squeeze opportunity. While investors are actively debating the impact of manipulation and volatility halts, many are looking ahead to the upcoming earnings release and company conference call as the potential catalysts to drive the next significant price move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assenagon Asset Management S.A. Takes Position in Halozyme Therapeutics, Inc. $HALO

Assenagon Asset Management S.A. acquired a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) during the 4th quarter, according to the company in its most recent filing...

Congress Asset Management Co. Cuts Position in Halozyme Therapeutics, Inc. $HALO

Congress Asset Management Co. decreased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 9.4% in the fourth quarter, according to its most recent filing with the Securities...

Halozyme Therapeutics, Inc. $HALO Shares Purchased by Allworth Financial LP

Allworth Financial LP lifted its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 322.5% during the third quarter, according to the company in its most recent Form 13F...

Why Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report?

Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Halozyme Therapeutics Touts $1.8B Revenue Outlook, ENHANZE Royalties and New Hypercon Deals at Conference

Halozyme Therapeutics (NASDAQ:HALO) executives highlighted the company's royalty-driven growth outlook and expanding subcutaneous drug delivery platform during remarks at the Citizens Life Sciences...

Alliancebernstein L.P. Trims Stake in Halozyme Therapeutics, Inc. $HALO

Alliancebernstein L.P. reduced its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 22.3% during the third quarter, according to its most recent 13F filing with the Securities...

Halozyme Therapeutics, Inc. $HALO Shares Acquired by Clark Capital Management Group Inc.

Clark Capital Management Group Inc. increased its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 14.4% in the 3rd quarter, according to the company in its most recent...

Brevan Howard Capital Management LP Sells 96,806 Shares of Halozyme Therapeutics, Inc. $HALO

Brevan Howard Capital Management LP decreased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 60.1% during the third quarter, according to the company in its most recent...

Aquatic Capital Management LLC Acquires Shares of 89,651 Halozyme Therapeutics, Inc. $HALO

Aquatic Capital Management LLC bought a new position in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Rating of "Hold" by Brokerages

Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Free Report) has earned an average rating of "Hold" from the twelve ratings firms that are currently covering the company, MarketBeat.com reports. One...

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$1.53	--	--	N/A
Q4 '25	$2.16	-$0.24	-111.11%	MISSED
Q3 '25	$1.63	$1.72	5.51%	BEAT
Q2 '25	$1.24	$1.54	23.77%	BEAT
Q1 '25	$0.92	$1.11	20.18%	BEAT

HALO
Halozyme Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest HALO News

HALOHalozyme Therapeutics Inc.